|
Reference |
Abstract authors |
Affiliation |
Abstract title |
Workshop |
Poster |
|
number |
|
|
|
|
number |
|
of abstract |
|
|
|
|
|
|
|
Workshop 17 |
|
|
|
|
viro00133 |
* Igor Mazur (1), Anhlan Darisuren (1), David Mitzner (2), Ludmilla Wixler (1), Ulrich Schubert (2), Stephan Ludwig (1) |
(1) WWU, Institute of Molecular Virology, Münster, Germany; (2) University of Erlangen-Nürnberg, Institute of Clinical and Molecular |
Novel functions of the influenza virus PB1-F2 protein |
Negative Strand RNA Viruses II |
NII001 |
|
|
Virology, Erlangen, Germany |
|
|
|
|
viro00412 |
* Rocio Coloma (1), Jaime Martín-Benito (1), José María Valpuesta (1), José Luis Carrascosa (1), |
(1) Centro Nacional de Biotecnología, Madrid, Spain |
Structure of an influenza virus recombinant ribonucleoprotein (RNP) |
Negative Strand RNA Viruses II |
NII002 |
|
Juan Ortín (1) |
|
|
|
|
|
viro00420 |
* Nuria Jorba (1), Silvia Juarez (1), Eva Torreira (1), Pablo Gastaminza (1), Estela Area (1), Juan Pablo Albar (1), Juan Ortín |
(1) Centro Nacional de Biotecnología, Madrid, Spain |
Proteomic Analysis of Intracellular Complexes Formed By the RNA Polymerase of Influenza Virus |
Negative Strand RNA Viruses II |
NII003 |
|
(1) |
|
|
|
|
|
viro00496 |
M. Pancratius (1), W. Ma (2), * S. Pleschka (1) |
(1) Justus-Liebig-University, Institute for Medical Virology, Giessen, Germany; (2) National Animal |
The Secondary Structure of the 5’-and 3’-End of Borna Disease Virus Genomic |
Negative Strand RNA Viruses II |
NII004 |
|
|
Disease Centre, B15, |
RNA Can Fold Into |
|
|
|
|
Ames, USA |
“Panhandle” and |
|
|
|
|
|
“Cork-Screw” |
|
|
|
|
|
Configuration |
|
|
|
viro00552 |
* Marius Ruf (1), Paul Verbruggen (1), Gjon Blakqori (1), Sybille Haid (1), Martin |
(1) University of Freiburg, Department of Virology, Freiburg, Germany; (2) GSF |
Dysregulation of Host Cell RNA Polymerase II by the La Crosse Virus |
Negative Strand RNA Viruses II |
NII005 |
|
Heidemann (2), Dirk Eick (2), Friedemann Weber (1) |
Research Center, Institute of Clinical Molecular Biology and Tumor Genetics, |
Virulence Factor NSs |
|
|
|
|
München, Germany |
|
|
|
|
viro00556 |
* Julia Kessler (1), Jacques R Kremer (1), |
(1) LNS, Institute of Immunology, |
IFN-[alpha]/[beta] signaling in MV |
Negative Strand RNA |
NII006 |
|
Claude P Muller (1) |
Luxembourg, Luxembourg |
infected PBMCs |
Viruses II |
|
|
viro00591 |
* Anika Kern (1), Stefan Finke (2), Karl-Klaus Conzelmann (1) |
(1) Max von Pettenkofer-Institute & Gene Center, LMU Munich, Germany; (2) Friedrich-Loeffler- |
The Matrix Protein of Rabies Virus and its Functions in Viral Assembly and Budding |
Negative Strand RNA Viruses II |
NII007 |
|
|
Institute, Insel Riems, |
|
|
|
|
|
Germany |
|
|
|
|
viro00602 |
* Kirsi Jääskeläinen (1), Pasi Kaukinen (2), Ekaterina Minskaya (3), Angelina Plyusnina |
(1) Haartman Institute, Department of Virology, Helsinki, Finland; (2) National Public Health |
Tula and Puumala hantavirus NSs proteins |
Negative Strand RNA Viruses II |
NII008 |
|
(1), Olli Vapalahti (1), Richard Elliott (4), Friedemann Weber (5), Antti Vaheri (1), |
Institute, Department of Viral Diseases and Immunology, Helsinki, Finland; (3) School of |
|
|
|
|
Alexander Plyusnin (1) |
Biomedical Sciences, Queen\\\\\\\'s University Belfast, Medical Biology Centre, Belfast, United |
|
|
|
|
|
Kingdom; (4) School of Biology, University of St |
|
|
|
|
|
Andrews, Centre for |
|
|
|
|
|
Biomolecular Sciences, |
|
|
|
|
|
St Andrews, United |
|
|
|
|
|
Kingdom; (5) Institut für Medizinische |
|
|
|
|
|
Mikrobiologie und |
|
|
|
|
|
Hygiene, Abteilung Virologie, Freiburg, Germany |
|
|
|
|
viro00605 |
A. Vidy (1), J. El Bougrini (2), M. Chelbi-Alix (2), * D. Blondel (1) |
(1) CNRS UMR2472, 91198, Gif sur Yvette, France; (2) CNRS FRE 2944, 94801, Villejuif, |
The nucleocytoplasmic rabies virus P protein counteracts |
Negative Strand RNA Viruses II |
NII009 |
|
|
France |
interferon response signaling by inhibiting both nuclear |
|
|
|
|
|
accumulation and |
|
|
|
|
|
DNA binding of |
|
|
|
|
|
STAT1 |
|
|
|
viro00608 |
* Adriane Marschalek (1), Stefan Finke (2), Martin Schwemmle (3), Daniel Mayer (3), Bernd Heimrich (3), Lothar Stitz (4), Karl- |
(1) MvP, LMU Munich, Germany; (2) FLI, Insel Riems, Germany; (3) ALU, Freiburg, Germany; (4) FLI, Tübingen, Germany |
Attenuation of rabies virus and immune stimulation by IRES-mediated translation of the P protein |
Negative Strand RNA Viruses II |
NII010 |
|
Klaus Conzelmann (1) |
|
|
|
|
|
viro00817 |
* Anne-Sophie Gosselin-Grenet (1), Laurent Roux (1) |
(1) University of Geneva medical School, Department of Microbiology and molecular medicine, Geneva, Switzerland |
Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors |
Negative Strand RNA Viruses II |
NII011 |
|
viro00882 |
* Ellen Krautkrämer (1), |
(1) Uniklinikum |
Hantaviruses enter |
Negative |
NII012 |
|
Simone Giese (1), Martin Zeier (1) |
Heidelberg, Nephrologie, Heidelberg, Germany |
from the apical surface and require DAF |
Strand RNA Viruses II |
|
|
viro00924 |
* Nicole Runkler (1), Stefan Niewiesk (2), Andrea Maisner (1) |
(1) Institute of Virology, Philipps-University Marburg, Marburg, Germany; (2) |
Importance of sorting signals in the measles virus wild-type |
Negative Strand RNA Viruses II |
NII013 |
|
|
Department of Veterinary Bioscience, The Ohio State University, Columbus, USA |
glycoproteins for replication in epithelial cells and lymphocytes |
|
|
|
viro01072 |
* Darisuren Anhlan (1), Igor Mazur (1), |
(1) WWU, Institute of Molecular Virology, |
Introduction of silent mutations |
Negative Strand RNA |
NII014 |
|
Christoph Scholtissek (1), Stephan Ludwig (1) |
Münster, Germany |
into the nucleoprotein gene |
Viruses II |
|
|
|
|
influences the |
|
|
|
|
|
replication of |
|
|
|
|
|
influenza A viruses |
|
|
|
viro01114 |
* Gülsah Gabriel (1), Astrid Herwig (1), |
(1) Philipps University Marburg, Institute of |
Adaptation of the Viral Polymerase to |
Negative Strand RNA |
NII015 |
|
Hans-Dieter Klenk (1) |
Virology, Marburg, Germany |
Importin Alpha Plays a Role in Interspecies Transmission of |
Viruses II |
|
|
|
|
Influenza Virus |
|
|
|
viro01123 |
Shohreh Mahmoudian (1), Sabrina Auerochs |
(1) Virological Institute, University Hospital, |
A cell-based method to quantify |
Negative Strand RNA |
NII016 |
|
(1), * Manfred Marschall (1) |
Erlangen, Germany |
modes of activation or inactivation of the influenza A |
Viruses II |
|
|
|
|
virus polymerase complex |
|
|
|
viro01211 |
* N. Penski (1), S. Kothlow (2), N. Ruggli |
(1) University of Freiburg, Freiburg, |
Role of the NS1 protein of avian |
Negative Strand RNA |
NII017 |
|
(3), A. Summerfield (3), B. Kaspers (2), J. Stech (4), G. Kochs (1), P. Staeheli (1) |
Germany; (2) University of Munich, Munich, Germany; (3) IVI, Mittelhäusern, Switzerland; (4) FLI, Riems, Germany |
influenza A virus strain SC35 (H7N7) in cell culture and in chickens |
Viruses II |
|
|
viro01280 |
* Eva-K. Pauli (1), |
(1) WWU, Institute of |
Influenza A virus |
Negative |
NII018 |
|
Mirco Schmolke (1), Christina Ehrhardt (1), Egbert Flory (2), Carsten Muenk (2), Stephan Ludwig (1) |
Molecular Virology, Muenster, Germany; (2) PEI, Langen, Germany |
induced expression of cellular APOBEC3G does not confer antiviral activity |
Strand RNA Viruses II |
|
|
viro01284 |
* Karl Dominik Conrad (1), Kristina Brauburger |
(1) Philipps University, Institute of Virology, |
Marburg virus VP24 inhibits viral |
Negative Strand RNA |
NII019 |
|
(1), Melanie Grosch (1), Elke Mühlberger (1) |
Marburg, Germany |
replication |
Viruses II |
|
|
viro01322 |
* Malin Stoltz (1), ClasAhlm (2), Åke Lundkvist (1), Jonas Klingström (1) |
(1) Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology, |
Hantavirus infection lead to decreased levels of serum interferon (IFN) - |
Negative Strand RNA Viruses II |
NII020 |
|
|
Stockholm, Sweden; (2) Umeå University, Department of Clinical Microbiology, Umeå, Sweden |
[lambda] in patients, and an established infection is insensitive to IFNs |
|
|
|
|
|
in vitro |
|
|
|
viro01327 |
* Martina Lobe (1), |
(1) Marburg University, |
Inhibition of the |
Negative |
NII021 |
|
Michael Schümann (1), Elke Mühlberger (1) |
Institute of Virology, Marburg, Germany |
Ebola virus polymerase by blocking the binding domain for the polymerase cofactor VP35 |
Strand RNA Viruses II |
|
|
viro01382 |
* Marion Poenisch (1), |
(1) University of |
A novel regulatory |
Negative |
NII022 |
|
Sandra Wille (1), Peter Staeheli (1), Urs Schneider (1) |
Freiburg, Dept. Virology, Freiburg, Germany |
sequence affecting viral RNA homeostasis in Borna disease virus |
Strand RNA Viruses II |
|
|
|
|
infection |
|
|
|
viro01394 |
* Eva Böttcher (1), |
(1) Philipps University |
Cleavage of |
Negative |
NII023 |
|
Tatyana Matrosovich |
Marburg, Institute of |
influenza virus |
Strand RNA |
|
|
(2), Mikhail |
Virology, Marburg, |
hemagglutinin by |
Viruses II |
|
|
Matrosovich (2), |
Germany; (2) NIMR, |
serine proteases |
|
|
|
Michaela Beyerle (1), |
London, UK |
HAT and |
|
|
|
Hans-Dieter Klenk (1), |
|
TMPRSS2 from |
|
|
|
Wolfgang Garten (1) |
|
human airway |
|
|
|
|
|
epithelium |
|
|
|
viro01397 |
* Patrick Heinemann |
(1) Institut für Virologie, |
The Cytoplasmic |
Negative |
NII024 |
|
(1), Katrin Schlie (1), |
Philipps Universität, |
and |
Strand RNA |
|
|
Frank Lennartz (1), |
Marburg, Germany |
Transmembrane |
Viruses II |
|
|
Wolfgang Garten (1) |
|
Domain are |
|
|
|
|
|
responsible for |
|
|
|
|
|
correct |
|
|
|
|
|
Oligomerization of |
|
|
|
|
|
Lassa Virus |
|
|
|
|
|
Glycoprotein |
|
|
|
|
|
Spikes |
|
|
|
viro01446 |
* Anna Överby (1), Ralf |
(1) Karolinska Institute, |
The cytoplasmic tail |
Negative |
NII025 |
|
Pettersson (1), Etienne Neve (1) |
LICR, Stockholm, Sweden |
of Uukuniemi virus ([I]Bunyaviridae[/I]) glycoproteins G[SUB]N[/SUB] and |
Strand RNA Viruses II |
|
|
|
|
G[SUB]C[/SUB] are |
|
|
|
|
|
important for viral assembly |
|
|
|
viro01463 |
* Kristina Schmidt (1), Sven Enterlein (2), Elke Mühlberger (1) |
(1) Institute of Virology, Marburg University, Marburg, Germany; (2) USAMRIID, Fort |
STRUCTURE OF THE MARBURG VIRUS REPLICATION |
Negative Strand RNA Viruses II |
NII026 |
|
|
Detrick, MD, USA |
PROMOTER |
|
|
|
viro01595 |
* Carolin Guenzel (1), |
(1) Mount Sinai School |
Recombinant |
Negative |
NII027 |
|
Megan Shaw (1), Sa Xiao (1), Peter Palese (1) |
of Medicine, Microbiology, New York City, New York |
Newcastle disease viruses (rNDV) expressing Nipah virus P, V and W |
Strand RNA Viruses II |
|
|
|
|
proteins potently downregulate |
|
|
|
|
|
expression of antiviral genes in human dendritic |
|
|
|
|
|
cells |
|
|
|
viro01647 |
Wiebke Handke (1), Detlev H. Krüger (1), * Andreas Rang (1) |
(1) University Hospital Charité, Institute of Virology, Berlin, |
TLR3-dependent activation of the IFN system by the |
Negative Strand RNA Viruses II |
NII028 |
|
|
Germany |
pathogenic Hantaan virus |
|
|
|
viro01670 |
* Ingeborg van Knippenberg (1), Vincent Leonard (2), Richard Elliott (1) |
(1) University of St Andrews, Centre for Biomolecular Sciences, St Andrews, United Kingdom; (2) Mayo |
Shut off of host cell transcription by a viral interferon antagonist. |
Negative Strand RNA Viruses II |
NII029 |
|
|
Clinic College of Medicine, Molecular |
|
|
|
|
|
Medicine Program, Rochester, USA |
|
|
|
|
viro01690 |
Emma Herrera (1), Patricia Barcenas (1), Guillermo |
(1) ENCB, IPN, VIROLOGY, DF, MEXICO; (2) ENMyH, |
A recombinant HN protein from mumps virus |
Negative Strand RNA Viruses II |
NII030 |
|
Perez_Ishiwara (2), * |
IPN, BIOMEDICINE, |
preserves the main |
|
|
|
Blanca Barron (1) |
DF, MEXICO |
properties of the |
|
|
|
|
|
complete viral HN |
|
|
|
viro01705 |
* Olivier Reynard (1), Page Audrey (1), Winfried Weissenhorn |
(1) Inserm U758, Laboratoire des Filovirus, Lyon, |
Identification of a domain involved in Ebolavirus VP40 |
Negative Strand RNA Viruses II |
NII031 |
|
(2), Viktor Volchkov (1) |
FRANCE; (2) Université Joseph Fourier, Grenoble, France |
binding to plasma membranes |
|
|
|
viro01725 |
* Eva Mittler (1), Jörg Wenigenrath (1), Larissa Kolesnikova (1), Stephan Becker (1) |
(1) Robert Koch Institute, Berlin, Germany |
Influence of the Marburg virus glycoprotein cytoplasmic tail on |
Negative Strand RNA Viruses II |
NII032 |
|
|
|
infectivity of viruslike particles |
|
|
|
viro01776 |
Martin Spiegel (1), Katharina Keisers (1), Andrea Thiel (1), Ankur Goyal (1), * Frank Hufert (1) |
(1) Institut für Virologie, Georg-August-Universität, Göttingen, Germany |
The NSs protein of Oropouche virus supresses transcription |
Negative Strand RNA Viruses II |
NII033 |
|
|
Workshop 18 |
|
|
|
|
viro00007 |
* Adriano Mondini (1), Roberta V M Bronzoni (2), Silvia H P Nunes (2), Francisco Chiaravalloti Neto (1), |
(1) FAMERP, DESC, S J Rio Preto, Brazil; (2) FAMERP, DDIP, S J Rio Preto, Brazil |
Phylogenetic and spatial analyses of a dengue outbreak in a medium sized city from Brazil |
Positive Strand RNA Viruses |
PSV001 |
|
Maurício L Nogueira (2) |
|
|
|
|
|
viro00037 |
Radka Komitova (1), * Neli Korsun (2), Petar Petrov (1), Snejana Gurova (2) |
(1) University Hospital St. Anna, Infectious Diseases Department, Sofia, Bulgaria; (2) National Center of |
Aseptic Meningitis in Bulgaria 2004 |
Positive Strand RNA Viruses |
PSV003 |
|
|
Infectious and Parasitic |
|
|
|
|
|
Diseases, Sofia, |
|
|
|
|
|
Bulgaria |
|
|
|
|
viro00428 |
* Chumporn Soowannayan (1), Jeff Cowley (1), Roger Pearson (1), Tristan |
(1) CSIRO Livestock Industries, Brisbane, Australia; (2) QIMR, Royal Brisbane |
Glycans attached to the gp116 and gp64 envelope proteins of yellow |
Positive Strand RNA Viruses |
PSV004 |
|
Wallis (2), Jeffrey Gorman (2), Wojtek Michalski (3), Peter Walker (3) |
Hospital, Brisbane, Australia; (3) CSIRO Livestock Industries, AAHL, Geelong, Australia |
head virus of Penaeus monodon shrimp |
|
|
|
viro00430 |
* Lorena Vega (1), Tsutomu Fujimura (1), |
(1) Institute of Biochemical |
Cis-acting signals that affects the |
Positive Strand RNA |
PSV005 |
|
Rosa Esteban (1) |
Microbiology (CSIC-University of Salamanca), Salamanca, Spain |
replication and ribonucleoprotein complexes formation in the 20S RNA |
Viruses |
|
|
|
|
narnavirus of S. |
|
|
|
|
|
cerevisiae |
|
|
|
viro00450 |
* Sabine Diedrich (1), Bernd Vollnberg (1), Eckart Schreier (1) |
(1) Robert Koch Institute, Berlin, Germany |
Long term shedding of Vaccine derived Poliovirus Type 1 in a German patient |
Positive Strand RNA Viruses |
PSV006 |
|
viro00492 |
* Michel de Vries (1), Krzysztof Pyrc (1), Ron Berkhout (2), Wilma Vermeulen-Oost (2), |
(1) AMC, Medical microbiology, Amsterdam, The Netherlands; (2) |
VIDISCA as typing technique for picornaviruses |
Positive Strand RNA Viruses |
PSV007 |
|
Ronald Dijkman (1), Maarten Jebbink (1), Sylvia Bruisten (2), Ben Berkhout (2), Paul Gruteke (2), Lia van der Hoek (1) |
Municipal Health Service, Public Health laboratory, Amsterdam, The Netherlands |
|
|
|
|
viro00527 |
* Kwai Peng Chan (1), |
(1) Singapore General |
Performance of 2 |
Positive |
PSV008 |
|
Xin Lai Bai (1), Siew Hoon Lim (1) |
Hospital, Singapore, Singapore |
new dengue antigen assays for early dengue diagnosis |
Strand RNA Viruses |
|
|
viro00595 |
Teemu Smura (1), Soile Blomqvist (1), Anja Paananen (1), * |
(1) National Public Health Institute, Helsinki, Finland |
NEW INSIGHT INTO EVOLUTION OF THE 5\'UTR OF |
Positive Strand RNA Viruses |
PSV009 |
|
Tapani Hovi (1), Merja Roivainen (1) |
|
ENTEROVIRUS GENOME |
|
|
|
viro00613 |
* Deborah Basso (1), Heinz-Jürgen Thiel (1), Norbert Tautz (1) |
(1) Universität Gießen, Institut für Virologie, Gießen, Germany |
Essential role of a host factor for the replication of certain pestivirus strains |
Positive Strand RNA Viruses |
PSV010 |
|
viro00669 |
* Tobias Hertzig (1), |
(1) Queen’s University |
Coronavirus |
Positive |
PSV011 |
|
John Ziebuhr (1) |
Belfast, School of Biomedical Sciences, Belfast, United Kingdom |
ORF1b-encoded enzymes: proteolytic release and functions in |
Strand RNA Viruses |
|
|
|
|
viral replication |
|
|
|
viro00681 |
* Sabrina Schrauf (1), Christian W. Mandl (1) |
(1) Medical University of Vienna, Clinical Institute |
TBEV NS2B/3 protease uses one |
Positive Strand RNA |
PSV012 |
|
|
of Virology, Vienna, Austria |
of two putative cleavage sites at the C-terminus of |
Viruses |
|
|
|
|
capsid protein |
|
|
|
viro00688 |
Shui-Mei Wang (1), Yu-Fen Chang (1), * Chin-Tien Wang (1) |
(1) National Yang-Ming University School of Medicine, Institute of |
Putative Dimerization Domain of Severe |
Positive Strand RNA Viruses |
PSV013 |
|
|
Clinical Medicine, Taipei, Taiwan |
Acute Respiratory Syndrome Coronavirus |
|
|
|
|
|
Nucleocapsid Protein Confers |
|
|
|
|
|
Ability to Efficiently |
|
|
|
|
|
Package Human APOBEC3G when |
|
|
|
|
|
Substituted for the |
|
|
|
|
|
Human |
|
|
|
|
|
Immunodeficiency Virus Nucleocapsid |
|
|
|
|
|
Domain |
|
|
|
viro00691 |
* Hitoshi Horie (1), Yuichi Fujii (1), Kouji Katabami (1), Masanori Iwama (1), Akira Yamada (2) |
(1) Ohu University, School of Pharmaceutical Sciences, Fukushima, Japan; (2) University of Shiga Prefecture, |
Characterisation of vaccine-derived polioviruses in Japan and an attempt to control the reversion of |
Positive Strand RNA Viruses |
PSV014 |
|
|
Department of Human |
polio vaccine |
|
|
|
|
Nursing, Shiga, Japan |
viruses to |
|
|
|
|
|
neurovirulent |
|
|
|
|
|
genotype |
|
|
|
viro00750 |
* Paula Andreia Silva (1), Sabine Diedrich |
(1) Robert Koch Institute, Berlin, |
Identification of enterovirus |
Positive Strand RNA |
PSV015 |
|
(1), Divina Cardoso (2), Eckart Schreier (1) |
Germany; (2) Universidade Federal de Goiás, Human |
serotypes by pyrosequencing |
Viruses |
|
|
|
Virology, Goiânia, Brazil |
|
|
|
|
viro00761 |
* Caroline Lüken (1), Hermann Müller (1) |
(1) Institute for Virology, Faculty of Veterinary Medicine, Leipzig, |
Generation of a Variant E/ Cu-1 reassortant virus of |
Positive Strand RNA Viruses |
PSV016 |
|
|
Germany |
the infectious bursal disease |
|
|
|
|
|
virus and its |
|
|
|
|
|
investigation in vitro |
|
|
|
viro00789 |
* Monira Noor (1), Mohammad Rafiqul Islam (1), Priya Mohan |
(1) Faculty of Veterinary Science, Pathology, Mymensingh, |
Development of infectious bursal disease virus |
Positive Strand RNA Viruses |
PSV017 |
|
Das (1), Caroline Lüken (2), Hermann Müller (2) |
Bangladesh; (2) Virology, Faculty of Veterinary Medicine, Leipzig, Germany |
vaccine candidates by reverse genetics |
|
|
|
viro00851 |
* Valentina Tefanova (1), Tatjana Tallo (1), Ljudmilla Priimägi (1) |
(1) National Institute for Health Development, Virology, Tallinn, |
Trends in the epidemiology of hepatitis A infection |
Positive Strand RNA Viruses |
PSV018 |
|
|
Estonia |
in Estonia |
|
|
|
viro01019 |
* Joern Klein (1), Preben Normann (1), Manzoor Hussain (2), Munir Ahmad (2), Soren Alexandersen (1) |
(1) National Veterinary Institute, Technical University of Denmark, Virology, Kalvehave, Denmark; (2) FAO, Islamabad, Pakistan |
Genetic characterisation of the recent foot-and-mouth disease virus subtype A/IRN/2005 |
Positive Strand RNA Viruses |
PSV019 |
|
viro01026 |
* Petri Susi (1), Outi |
(1) University of Turku, |
Sequence variation |
Positive |
PSV020 |
|
Lipiäinen (1), Anna Niinimäki (1), Sasu Järvinen (1), Merja Roivainen (2), Timo Hyypiä (1) |
Virology, Turku, Finland; (2) National Public Health Institute, Enterovirus Laboratory, Helsinki, Finland |
of Coxsackievirus A7 strains of Human enterovirus A species |
Strand RNA Viruses |
|
|
viro01028 |
* Anil Kumar (1), Sven Miller (1), Ralf |
(1) University of Heidelberg, Department |
Characterization of Nuclear Localized |
Positive Strand RNA |
PSV021 |
|
Bartenschlager (1), Sandra Buehler (1) |
of Molecular Virology, Heidelberg, Germany |
NS5 of Dengue Virus |
Viruses |
|
|
viro01133 |
* Anna Jackova (1), Michaela Novackova (1), Mariana Kolesarova (2), Viviane Benetka (3), Dieter |
(1) University of Veterinary Medicine, Kosice, Slovakia; (2) UPJS, Kosice, Slovakia; (3) University of |
Bovine coronavirus: Analysis of S1 subunit of isolates originating from Austria and |
Positive Strand RNA Viruses |
PSV022 |
|
Klein (3), Karin Mostl (3), Stefan Vilcek (1) |
Veterinary Medicine, Vienna, Austria |
Slovakia |
|
|
|
viro01202 |
* Vera Schregel (1), Beate Kümmerer (2), Romy Kerber (2), Norbert Tautz (1) |
(1) Universität Gießen, Institut für Virologie, Gießen, Germany; (2) Bernhard-Nocht-Institut für Tropenmedizin, |
Overexpression of a host-cell factor inhibits yellow fever virus RNA replication |
Positive Strand RNA Viruses |
PSV023 |
|
|
Abteilung für Virologie, Hamburg, Germany |
|
|
|
|
viro01203 |
* Iris Stallkamp (1), |
(1) JLU Giessen, Institut |
Mapping of |
Positive |
PSV024 |
|
Svenja Wiese (1), |
für Virologie, Giessen, |
mutations for |
Strand RNA |
|
|
Heinz-Jürgen Thiel (1) |
Germany |
differentiation of |
Viruses |
|
|
|
|
highly virulent |
|
|
|
|
|
FCoV from its |
|
|
|
|
|
harmless biotype |
|
|
|
viro01250 |
* Rui Galão (1), Ashwin Chari (2), Antonio Mas |
(1) University Pompeu Fabra, Barcelona, |
Cellular LSm1-7 complex required |
Positive Strand RNA |
PSV025 |
|
(3), Utz Fischer (2), Juana Díez (1) |
Spain; (2) Biozentrum, Würzburg, Germany; (3) University Castilla-La Mancha, Albacete, Spain |
for Brome Mosaic Virus RNA translation and replication directly binds to essential RNA translation |
Viruses |
|
|
|
|
and replication signals |
|
|
|
viro01308 |
* K. Wolthers (1), K. Benschop (1), J. Schinkel (1), R. Molenkamp (1), X. Thomas (1), I. |
(1) AMC, Medical Microbiology, Amsterdam, The Netherlands; (2) OLVG, Medical Microbiology, |
Importance of human parechoviruses as a cause for sepsis/meningitis in |
Positive Strand RNA Viruses |
PSV026 |
|
Spijkerman (2), H. Kraakman (3), D. Pajkrt (4) |
Amsterdam, The Netherlands; (3) OLVG, Pediatrics, Amsterdam, The Netherlands; (4) Emma Children´s |
infants |
|
|
|
|
Hospital, Pediatric |
|
|
|
|
|
Infectious Diseases, |
|
|
|
|
|
Amsterdam, The |
|
|
|
|
|
Netherlands |
|
|
|
|
viro01333 |
* Daniel Ruzek (1), Vlasta Danielova (2), Jaroslava Holubova (2), Jan Kopecky (1), |
(1) University of South Bohemia and Academy of Sciences of the Czech Republic, |
Molecular evolution of tick-borne encephalitis virus in the Central Europe |
Positive Strand RNA Viruses |
PSV027 |
|
Libor Grubhoffer (1) |
Faculty of Science and Institute of Parasitology, Ceske Budejovice, Czech Republic; (2) National Institute of |
over 50 years |
|
|
|
|
Public Health, Centre of |
|
|
|
|
|
Epidemiology and Microbiology, Prague, Czech Republic |
|
|
|
|
viro01428 |
* Hervé Moulin (1), Torsten Seuberlich (1), Oliver Bauhofer (1), Lea Bennett (1), Jon- |
(1) Institute of Virology and Immunoprophylaxis, Mittelhäusern, |
Nonstructural proteins NS2-3 and NS4A of classical swine fever virus: |
Positive Strand RNA Viruses |
PSV028 |
|
Duri Tratschin (1), Martin A. Hofmann (1), Nicolas Ruggli (1) |
Switzerland |
essential features for infectious particle formation |
|
|
|
viro01469 |
Sami Oikarinen (1), * Sisko Tauriainen (1), Didier Hober (2), Bernadette Lucas (2), |
(1) University of Tampere, Department of Virology, Tampere, Finland; (2) University |
Enterovirus prevalence in different European populations |
Positive Strand RNA Viruses |
PSV029 |
|
Peter Muir (3), Lisa Brown (3), Keith Taylor (4), Glyn Stanway (5), Cigdem Williams (5), Christos Bartsocas (6), Andriani Vazeou (6), |
hospital, Lille, France; (3) Kings College, London, UK; (4) Queen Mary &Westfield College, London, UK; (5) University of Essex, |
|
|
|
|
Evangelos Bozas (6), Maria Dokopoulou (6), Johnny Ludvigsson (7), |
Colchester, UK; (6) National University, Athens, Greece; (7) |
|
|
|
|
Heikki Hyöty (1) |
Linköping University, |
|
|
|
|
|
Lindköping, Sweden |
|
|
|
|
viro01479 |
* K Benschop (1), C Williams (2), G Pollakis (1), J Schinkel (1), K |
(1) Academic Medical Center, Medical Microbiology, |
Recombination evidence within the Human |
Positive Strand RNA Viruses |
PSV030 |
|
Wolthers (1), G Stanway (2) |
Amsterdam, The Netherlands; (2) University of Essex, Biological Science, Colchester, United |
Parechovirus group |
|
|
|
|
Kingdom |
|
|
|
|
viro01543 |
* Judy Mitchell (1), Kai- |
(1) The Royal |
Development of a |
Positive |
PSV031 |
|
Biu Shiu (1), Harriet Brooks (1), Joe Brownlie (1), Kerstin Erles (1) |
Veterinary College, PID, Hatfield, United Kingdom |
quantitative realtime PCR for the detection of canine respiratory coronavirus |
Strand RNA Viruses |
|
|
viro01551 |
* German Tapia (1), Ondrej Cinek (2), |
(1) Norwegian Institute of Public Health, Oslo, |
Longitudinal observation of |
Positive Strand RNA |
PSV032 |
|
Kjersti S. Ronnigen (1), Bjorn Grinde (1) |
Norway; (2) University Hospital Motol, Prague, The Czech Republic |
Parechovirus in Norwegian Infants |
Viruses |
|
|
viro01575 |
* C. Claus (1), W.-P. Tzeng (2), T. K. Frey (2), J. Hofmann (1), K.Überla (3), U. G. |
(1) University of Leipzig, Leipzig, Germany; (2) Georgia State University, Atlanta, |
Defining important functions of rubella virus structural proteins in virus |
Positive Strand RNA Viruses |
PSV033 |
|
Liebert (1) |
USA; (3) Ruhr University Bochum, Bochum, Germany |
entry and replication |
|
|
|
viro01600 |
* Xin Lai Bai (1), Kwai Peng Chan (1), Siew Hoon Lim (1) |
(1) Singapore General Hospital, Singapore, Singapore |
Evaluation of six immunoassays for the detection of Rubella virus- |
Positive Strand RNA Viruses |
PSV034 |
|
|
|
specific immunoglobulin M antibodies |
|
|
|
viro01601 |
* Xin Lai Bai (1), Kwai Peng Chan (1), Siew Hoon Lim (1) |
(1) Singapore General Hospital, Singapore, Singapore |
Diagnosis of dengue virus infection: Performance of |
Positive Strand RNA Viruses |
PSV035 |
|
|
|
Panbio Dengue antigen and IgM and IgG antibody |
|
|
|
|
|
assays |
|
|
|
viro01642 |
* Violaine Olivier (1), Philippe Blanchard (1), Frank Schurr (1), |
(1) Agence Francaise de Sécurité Sanitaire des Aliments, sophia |
Molecular Characterization and Phylogenetic |
Positive Strand RNA Viruses |
PSV036 |
|
Olivier Celle (1), Magali Ribière (1), Richard Thièry (1) |
antipolis, France |
Analysis of Chronic Bee Paralysis Virus, a Honey Bee Virus |
|
|
|
viro01658 |
* Alessio Lorusso (1), Bert Jan Haijema (2), Nicola Decaro (1), |
(1) Faculty of Veterinary Medicine, Animal Health and Well-being, |
Identification and biochemical characterisation of |
Positive Strand RNA Viruses |
PSV037 |
|
Pepijn Schellen (2), Canio Buonavoglia (1), Raoul J. de Groot (2) |
Bari, Italy; (2) , Faculty of Veterinary Medicine, Infectious and Immunology, Utrecht, The Netherlands |
a novel protein unique to canine coronavirus type I |
|
|
|
viro01682 |
* J. M. Bible (1), P. |
(1) Guy’s and St. |
Molecular |
Positive |
PSV038 |
|
Pantelidis (2), J. W. A. Bendig (3), P. Earl (3), C. Y. W. Tong (1) |
Thomas’ NHS Foundation Trust, Infection and Immunology, London, |
epidemiology of Enterovirus 71 (EV71) infection in the UK 1998-2006 |
Strand RNA Viruses |
|
|
|
UK; (2) National Heart and Lung Institute, Imperial College,, Dept of Population Genetics & Gene Therapy, London, UK; (3) |
|
|
|
|
|
Westpark Hospital, Dept of Microbiology, Epsom, Surrey, UK |
|
|
|
|
viro01688 |
* Majid Laassri (1), Kathleen Lottenbach |
(1) Food and Drug Administration, CBER, |
Effect of different vaccination |
Positive Strand RNA |
PSV039 |
|
(2), Robert Belshe (2), Stanley Plotkin (3), |
Bethesda, USA; (2) Saint Louis University, |
schedules on the excretion and |
Viruses |
|
|
Konstantin Chumakov (1) |
Saint Louis, USA; (3) University of Pennsylvania and Aventis Pasteur, |
reversion of attenuated poliovirus |
|
|
|
|
Doylestown, USA |
|
|
|
|
viro01698 |
* Albrecht von Brunn (1), Carola Teepe (1), |
(1) Max-von-Pettenkofer Institut, |
Analysis of Intraviral Protein- |
Positive Strand RNA |
PSV040 |
|
Caroline Friedel (2), Ralf Zimmer (2), Jeremy Simpson (3), Rainer Pepperkok (3), Rhonda Roberts (4), Ralph Baric (4), Jürgen |
Virology, München, Germany; (2) LMU, Institut für Informatik, München, Germany; (3) EMBL, Heidelberg, Germany; (4) University |
Protein Interactions of the SARS Coronavirus ORFeome |
Viruses |
|
|
Haas (1) |
of North Carolina, Chapel Hill, USA |
|
|
|
|
viro01716 |
* Elisabet Witsø (1), Ondrej Cinek (2), Bjørn Grinde (1), Kjersti S. Rønningen (1) |
(1) Norwegian Institute of Public Health, Oslo, Norway; (2) Motol University Hospital, Prague, The Czech |
Prevalence and risk factors for enterovirus and adenovirus in stool samples from |
Positive Strand RNA Viruses |
PSV041 |
|
|
Republic |
Norwegian infants |
|
|
|
viro01727 |
C. Juenemann (1), Y. Song (1), G. Bassili (1), D. Goergen (1), J. Henke (1), * M. Niepmann (1) |
(1) University of Giessen, Institute of Biochemistry, Giessen, Germany |
Picornavirus Internal ribosomal entry sites can stimulate translation of |
Positive Strand RNA Viruses |
PSV042 |
|
|
|
upstream genes |
|
|
|
viro01732 |
* M. Niepmann (1), J. |
(1) University of |
Analysis of the |
Positive |
PSV043 |
|
Zheng (1) |
Giessen, Institute of Biochemistry, Giessen, Germany |
oligomeric state of an RNA-binding protein - a discontinuous |
Strand RNA Viruses |
|
|
|
|
native protein gel electrophoresis |
|
|
|
|
|
system |
|
|
|
viro01791 |
* Andreas Kurth (1), Sascha Engel (1), Douglas E Skilling (2), Andreas Nitsche (1), Alvin W Smith (2) |
(1) Robert Koch-Institut, Centre for Biological Safety, Berlin, Germany; (2) Oregon State University, Laboratory for |
Zoonotic vesiviruses associated with human hepatitis |
Positive Strand RNA Viruses |
PSV044 |
|
|
Calicivirus Studies, |
|
|
|
|
|
Corvallis OR, USA |
|
|
|
|
viro01862 |
* Denise Henrych (1), Susanne Lerch (1), Volker Moennig (1), Stefanie Bendfeldt (1), |
(1) University of Veterinary Medicine Hannover, Institute of Virology, Hannover, |
Characterization of antigenic domains of the protein E[SUP]rns[/SUP] |
Positive Strand RNA Viruses |
PSV045 |
|
Irene Greiser-Wilke (1) |
Germany |
from Classical swine fever virus |
|
|
|
|
|
(CSFV) and Bovine viral diarrhea virus |
|
|
|
|
|
(BVDV) |
|
|
|
viro01866 |
* Farideh Ghazi (1), Bahareh Dabirmanesh |
(1) Iran University of Medical Sciences, |
Molecular analysis of proteolytic |
Positive Strand RNA |
PSV046 |
|
(2), Frooz Sorooshi (1), Glyn Stanway (3) |
Microbiology, Tehran, Iran; (2) Azahra University, Biochemistry, Tehran, Iran; (3) Essex University, Molecular |
activity of human Parechovirus type1 2A protein |
Viruses |
|
|
|
Virology, Colchester, UK |
|
|
|
|
|
Workshop 19 |
|
|
|
|
viro00080 |
* M Kummer (1), NM Turza (1), P Muhl-Zurbes (1), M |
(1) Univ.Hosp. Erlangen, Dermatology, Erlangen, Germany; (2) |
HSV-1 Induces CD83 Degradation in mature Dendritic |
Viral Persistence and Immune |
VPI001 |
|
Lechmann (1), C Boutell (2), RS Coffin (3), RD Everett (2), A Steinkasserer (1), AT Prechtel (1) |
Univ. Glasgow, MRC Virol., Inst. Virol., Glasgow, UK; (3) Univ.Coll. London, Immunol. Mol. Pathol., London, UK |
Cells (mDCs) with IE Kinetics via the Cellular Proteasome |
Evasion |
|
|
viro00085 |
J. Eisemann (1), P. |
(1) Univ. Hosp. |
Infection of mature |
Viral |
VPI002 |
|
Muhl-Zurbes (1), A. Steinkasserer (1), * M. Kummer (1) |
Erlangen, Dermatology, Erlangen, Germany |
DCs with HSV-1 interferes with the IFN signaling pathway |
Persistence and Immune Evasion |
|
|
viro00115 |
* Katrin Besold (1), Gabriele Hahn (2), Bodo Plachter (1) |
(1) University of Mainz, Institute of Virology, Mainz, Germany; (2) |
Impact of HCMV US2-US11-Mediated Immune |
Viral Persistence and Immune |
VPI004 |
|
|
LMU Munich, Max von |
Evasion on MHC |
Evasion |
|
|
|
Pettenkofer Institute, |
Class I |
|
|
|
|
Munich, Germany |
Presentation of pp65- and IE1Derived Peptides |
|
|
|
viro00435 |
* Marie-Edith Lafon (1), Muriel Faure-Della |
(1) University Bordeaux 2, Virology EA2968, |
Human Cytomegalovirus |
Viral Persistence |
VPI005 |
|
Corte (1), Noël Magnin (1), Lionel Couzi (2), Julie Dechanet-Merville (3), Pierre Merville (2), Hervé Fleury (1), Isabelle Garrigue (1) |
Bordeaux, France; (2) University Hospital Bordeaux, Renal Transplantation Unit, Bordeaux, France; (3) University Bordeaux 2, |
(HCMV) genes natural polymorphism and quasispecies distribution in renal transplant |
and Immune Evasion |
|
|
|
Immunology UMR CNRS 5164 CIRID, |
recipients |
|
|
|
|
Bordeaux, France |
|
|
|
|
viro00455 |
* Misael L. Silva (1), Joselma Siqueira-Silva (1), Marcelo Bibancos (1), Fernanda P. Yeda |
(1) University of Sao Paulo, Microbiologia, Sao Paulo, Brazil |
Human adenovirus 41 infects lymphocytes |
Viral Persistence and Immune Evasion |
VPI006 |
|
(1), Charlotte M. Harsi |
|
|
|
|
|
(1) |
|
|
|
|
|
viro00543 |
Maurits de Koning (1), |
(1) Delft Diagnostic |
Betapapillomavirus |
Viral |
VPI008 |
|
Linda Struijk (2), Jan ter Schegget (3), * Mariet Feltkamp (4) |
Laboratory, Voorburg, The Netherlands; (2) Leiden University Medical Center, Medical |
es frequently persist in the skin of healthy individuals |
Persistence and Immune Evasion |
|
|
|
Microbiology, Leiden, The Netherlands; (3) |
|
|
|
|
|
DDL, Voorburg, The Netherlands; (4) LUMC, Leiden, The |
|
|
|
|
|
Netherlands |
|
|
|
|
viro00786 |
* Ken Nishimura (1), Mahito Nakanishi (1) |
(1) National Institute of Advanced Industrial Science and |
Non-cytopathic Sendai Virus Strain Escapes from Type |
Viral Persistence and Immune |
VPI010 |
|
|
Technology, Biotherapeutic Research Laboratory, Tsukuba, Ibaraki, Japan |
I Interferon Induction by Mutation in L protein |
Evasion |
|
|
viro00881 |
Eva Kolwijck (1), Jolanda Hoefnagel (1), Josje Kingma (2), |
(1) Radboud University Medical Center, Medical Microbiology, Nijmegen, |
Virus excretion and immunological markers in the late |
Viral Persistence and Immune |
VPI011 |
|
Anneke Schoenmaker (3), Willem Melchers (1), * Jochem Galama (1) |
the Netherlands; (2) Bartiméus, Inst for visual handicapped, Doorn, Netherlands; (3) Viataal, Inst for |
progression of symptoms in congenital rubella syndrome |
Evasion |
|
|
|
deafness, St |
|
|
|
|
|
Michielsgestel, Netherlands |
|
|
|
|
viro00884 |
Gennadiy Zelinskyy (1), Frank Krux (1), * Ulf Dittmer (1) |
(1) Institute for Virology, Essen, Germany |
Virus-infected dendritic cells expand CD4+ regulatory T cells during acute Friend |
Viral Persistence and Immune Evasion |
VPI012 |
|
|
|
retrovirus infection |
|
|
|
|
|
and contribute to |
|
|
|
|
|
the development of a chronic infection. |
|
|
|
viro00914 |
* Päivi Norja (1), Kati Hokynar (1), Peter Simmonds (2), Maria |
(1) University of Helsinki, Helsinki, Finland; (2) University |
Bioportfolio:lifelong tissue persistence of new and old |
Viral Persistence and Immune |
VPI013 |
|
Söderlund-Venermo (1), Klaus Hedman (3) |
of Edinburgh, Edinburgh, UK; (3) Helsinki University Central Hospital Laboratory, Helsinki, Finland |
parvoviruses |
Evasion |
|
|
viro01002 |
* Anna Heinzelmann |
(1) Georg-Speyer-Haus, |
APOBEC3G in |
Viral |
VPI014 |
|
(1), Andreas Meyerhans (2), Ursula Dietrich (1), Hagen von Briesen (3) |
Frankfurt am Main, Germany; (2) Universität des Saarlandes, Homburg Saar, Germany; (3) Fraunhofer Institut fuer |
infected myeloid cells as an antiviral target |
Persistence and Immune Evasion |
|
|
|
Biomedizinische |
|
|
|
|
|
Technik, St. Ingbert, Germany |
|
|
|
|
viro01155 |
Lev Goldfarb (1), |
(1) National Institute of |
Viluisk |
Viral |
VPI015 |
|
Ekaterina Subbotina |
Neurological Disorders, |
encephalomyelitis: |
Persistence |
|
|
(2), Evgeniy Savilov (3), Vsevolod Vladimirtsev (4), * Alexander Chepurnov |
NIH, Bethesda, MD, USA; (2) SRCVB Vector, Novosibirsk, Russia; (3) Institute of |
an emerging infectious disease |
and Immune Evasion |
|
|
(5) |
epidemiology, Irkutsk, Russia; (4) Institute of Health, Yakutsk, |
|
|
|
|
|
Russia; (5) Michigan Nanotechnology Institute for Medicine |
|
|
|
|
|
and Biological Sciences, University of Michigan, Ann Arbor, USA |
|
|
|
|
viro01158 |
Yu-Tsih Shih (1), * Wei-June Chen (1) |
(1) Chang Gung University, Public Health and |
Identification of eukaryotic translation initiation |
Viral Persistence and Immune |
VPI016 |
|
|
Parasitology, Kwei-San, Tao-Yuan, TAIWAN |
factor 5A (eIF5A) and its potential role during dengue 2 virus infection in |
Evasion |
|
|
|
|
mosquito C6/36 cells |
|
|
|
viro01208 |
* Kerstin Schneider (1), |
(1) IMH, Virology, |
Human |
Viral |
VPI017 |
|
Ursula Meyer-König (1), Frank T. Hufert (2) |
Freiburg, Germany; (2) Virology, Göttingen, Germany |
cytomegalovirus impairs the function of plasmacytoid dendritc cells |
Persistence and Immune Evasion |
|
|
|
|
isolated from tonsil |
|
|
|
|
|
but not the function |
|
|
|
|
|
of pDC isolated from blood |
|
|
|
viro01230 |
* Shadi Salloum (1), Cesar Oniangue-Ndza (1), Marc aus dem Siepen (1), Stefan Ross (1), Michael |
(1) University of Essen, Institute of Virology, Essen, Germany |
Escape in an HCV CTL epitope exacts fitness costs |
Viral Persistence and Immune Evasion |
VPI018 |
|
Roggendorf (1), Joerg Timm (1), Sergei Viazov (1) |
|
|
|
|
|
viro01235 |
* Bernd Köberlein (1), Axel Zurhausen (2), Ruth Chin (3), Hanswalter Zentgraf |
(1) Institute of Pathology, Molecular Pathology, Tuebingen, Germany; (2) |
Suppressor of cytokine signaling-3 (SOCS-3) is induced by |
Viral Persistence and Immune Evasion |
VPI019 |
|
(4), Reinhard Kandolf (1), Thomas Bock (1) |
Pathology, Department of Pathology, Freiburg, Germany; (3) Clinical center for research |
Hepatitis B Virus in HuH7 cells and liver tissue |
|
|
|
|
excellence, Department of Medicine, Melbourne, |
|
|
|
|
|
Australia; (4) German Cancer Research |
|
|
|
|
|
Center, Applied Tumorvirology, Heidelberg, Germany |
|
|
|
|
viro01254 |
* Lorenz Jäger (1), Anja Ehrhardt (1) |
(1) Max von Pettenkofer Institute, Virology, |
Gene deleted adenoviral vector |
Viral Persistence |
VPI020 |
|
|
Munich, Germany |
genomes do not form concatemers |
and Immune Evasion |
|
|
|
|
or circular |
|
|
|
|
|
monomers: |
|
|
|
|
|
Implications for |
|
|
|
|
|
persistence of |
|
|
|
|
|
recombinant |
|
|
|
|
|
adenoviral vectors |
|
|
|
viro01255 |
* Antje Knöll (1), Tilo Schlittenbauer (1), Bernd Krüger (2), Bernhard Krämer (2), Wolfgang Jilg (1), Arndt Hartmann (3) |
(1) University of Regensburg, Medical Microbiology, Regensburg, Germany; (2) University of Regensburg, Internal |
Frequent BK virus DNA detection in renal allograft recipients |
Viral Persistence and Immune Evasion |
VPI021 |
|
|
Medicine, Regensburg, Germany; (3) University of Regensburg, Pathology, Regensburg, Germany |
|
|
|
|
viro01260 |
Caroline Staib (1), * Simone Backes (1), |
(1) GSF - TU München, Institut f. Virologie, |
C7L host range gene is essential |
Viral Persistence |
VPI022 |
|
Karin Sperling (2), Gerd Sutter (2) |
München, Germany; (2) Paul Ehrlich Institut, Abteilung f. Virologie, Langen, Gerermany |
for vaccinia virus MVA life cycle in human and murine cells |
and Immune Evasion |
|
|
viro01315 |
* Katja Maurer (1), Ellen Harrer (1), Andreas Goldwich (2), |
(1) University of Erlangen-Nuremberg, Department of Medicine |
Analysis of CTL mediated immune selection in a |
Viral Persistence and Immune |
VPI023 |
|
Kathrin Eismann (1), Birgit Schätz (1), Sandra Müller (1), Silke Bergmann (1), Thomas Harrer (1) |
III Immunology, Erlangen, Germany; (2) University of Erlangen-Nuremberg, Clinical and Molecular Virology, Erlangen, Nuermberg |
dominant HLA B8restricted CTL Epitope in Nef |
Evasion |
|
|
viro01392 |
* Markus Lantermann |
(1) Paul-Ehrlich-Institut, |
Vaccinia virus |
Viral |
VPI024 |
|
(1), Astrid Schwantes (1), Katja Sliva (1), Gerd Sutter (1), Barbara Schnierle (1) |
Virology, Langen, Germany |
double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated |
Persistence and Immune Evasion |
|
|
|
|
gene silencing in |
|
|
|
|
|
mammalian cells |
|
|
|
viro01471 |
* Andreas Busche (1), Andre Bleich (2), Corinna Benkartek (1), Martin Messerle (1) |
(1) Medical School Hannover, Institute of Virology, Hannover, Germany; (2) Medical School Hannover, |
AN MCMV IE1 DELETION MUTANT ESTABLISHES AND |
Viral Persistence and Immune Evasion |
VPI025 |
|
|
Institute of Laboratory |
REACTIVATES |
|
|
|
|
Animal Science, |
FROM LATENCY |
|
|
|
|
Hannover, Germany |
|
|
|
|
viro01544 |
* Eva Gellermann (1), Wiebke Albrecht (1), Abel Viejo-Borbolla (1), Thomas F. Schulz (1) |
(1) Hanover Medical School, Institute of Virology, Hanover, Germany |
Interaction of KSHV LANA with USP7: Implications for p53 function |
Viral Persistence and Immune Evasion |
VPI026 |
|
viro01568 |
* Mathias Thurau (1), Gaby Sander (1), |
(1) Clinical Center, University of Erlangen, |
K13 of Human Herpesvirus Type-8 |
Viral Persistence |
VPI027 |
|
Kristina Weinländer (1), Elisabeth Naschberger (1), Khaled Alkharsah (2), Thomas Schulz (2), Michael Stürzl (1) |
Division for Molecular and Experimental Surgery, Erlangen, Germany; (2) Hannover Medical School, Institute of Virology, |
Protects Against Superoxide-Induced Cell Death |
and Immune Evasion |
|
|
|
Hannover, Germany |
|
|
|
|
viro01589 |
Avis Dafa-Berger (1), Slava Rom (1), Tracey Baas (2), Bryan Paeper (2), Sean Proll (2), |
(1) Ben Gurion Univ, Microbiology and Immunology, Beer Sheva, Israel; (2) |
Using functional genomics to unravel the governing |
Viral Persistence and Immune Evasion |
VPI028 |
|
Michael Katze (2), * Bracha Rager-Zisman (1) |
University of Washington, Microbiolgy, Seattle, USA |
mechanisms of persistent virus infection |
|
|
|
viro01630 |
* Cindy Gutzeit (1), Martin J. Raftery (1), Thomas Giese (2), |
(1) Charite Medical School, Institute of Virology, Berlin, |
Interference of Varicella-Zoster Virus strains with |
Viral Persistence and Immune |
VPI029 |
|
Craig Morita (3), Guenther Schoenrich (1) |
Germany; (2) University of Heidelberg, Institute of Immunology, Heidelberg, Germany; (3) University of Iowa, Department of Internal |
the CD1 antigen presenting system in immature Dendritic Cells |
Evasion |
|
|
|
Medicine, Iowa, USA |
|
|
|
|
viro01748 |
* Michael Kleines (1), Simone Scheithauer (1), Martin Häusler (2) |
(1) UK Aachen, Virology, Aachen, Germany; (2) UK Aachen, Pediatrics, |
MHV-68 infection of mice: an animal model of human cardiac disease |
Viral Persistence and Immune Evasion |
VPI031 |
|
|
Aachen, Germany |
related to EBV infection |
|
|
|
viro01777 |
* Martin Raftery (1), |
(1) Institute of Virology, |
Human |
Viral |
VPI032 |
|
Günther Schönrich (1) |
Charite Campus Mitte, Berlin, Germany |
Cytomegalovirus interference in CD1 antigen presentation |
Persistence and Immune Evasion |
|
|
viro01780 |
* Martin Raftery (1), Elisabeth MönckeBuchner (1), Hideo |
(1) Institute of Virology, Charite Campus Mitte, Berlin, Germany; (2) |
Unravelling the interaction of HCMV with |
Viral Persistence and Immune |
VPI033 |
|
Matsumura (2), Thomas Giese (3), Monika Reuter (1), Ryohei Terauchi (2), Günther Schönrich (1), Detlev Krüger (1) |
Iwate Biotechnology Research Center, Kitakami, Japan; (3) Institute of Immunology, University of Heidelberg, Heidelberg, |
dendritic cells using SuperSAGE |
Evasion |
|
|
|
Germany |
|
|
|
|
viro01871 |
* Tsan Yuk Lam (1), Frederick, Chi-Ching Leung (1) |
(1) The University of Hong Kong, Department of Zoology, Hong Kong, Hong Kong, China |
Different modes of viral persistence of highly pathogenic avian influenza (HPAI) and low pathogenic avian |
Viral Persistence and Immune Evasion |
VPI034 |
|
|
|
influenza (LPAI) viruses revealed by their evolutions |
|
|
|
viro01877 |
Jurica Arapovic (1), Tihana Lenac (1), * Marina Babic (1), Ronald Antulov (1), |
(1) Medical faculty, Histology and Embryology, Rijeka, Croatia |
Resistance of RAE-1[delta] to downmodulation by MCMV |
Viral Persistence and Immune Evasion |
VPI035 |
|
Astrid Krmpotic (1), Bojan Polic (1), Stipan Jonjic (1) |
|
|
|
|
|
viro01887 |
* Tobias Keßler (1), Michael Reich (2), Eva Tolosa (3), Christoph Driessen (2), Klaus |
(1) Medical Virology, Tübingen, Germany; (2) Medicine II, Tübingen, Germany; (3) Hertie |
HCMV interferes with the antigen presentation pathways in |
Viral Persistence and Immune Evasion |
VPI036 |
|
Hamprecht (1), |
Institute for Clinical |
dendritic cells at |
|
|
|
Gerhard Jahn (1) |
Brain Research, |
multiple levels |
|
|
|
|
Tübingen, Germany |
|
|
|
|
|
Workshop 20 |
|
|
|
|
viro00015 |
* Keivan Zandi (1), |
(1) Bushehr University |
Antiherpetic activity |
Antivirals and |
AVR001 |
|
Maryam Salimi (1), Kohzad Sartavi (2) |
of Medical Sciences, Persian Gulf Health Research Center, Bushehr, Iran; (2) Jahad-Keshavarzi |
of the red marine alga from Persian gulf, Gracilaria salicornia |
Resistance |
|
|
|
Research Center, |
|
|
|
|
|
Botany, Bushehr, Iran |
|
|
|
|
viro00118 |
* Martin Michaelis (1), Anh Ha (1), Hans Wilhelm Doerr (1), Jindrich Cinatl (1) |
(1) Klinikum d. J. W. Goethe-Universität, Institut für Medizinische Virologie, Frankfurt am Main, Germany |
Valproic acid stimulates human cytomegalovirus replication in endothelial cells |
Antivirals and Resistance |
AVR002 |
|
viro00473 |
* Tatiana Betakova (1), Katarina Balintova (2), |
(1) Institute of Virology, Bratislava, Slovak |
Preparation of recombinant |
Antivirals and Resistance |
AVR003 |
|
Anna Ohradanova (1), Peter Kabat (2) |
Republic; (2) Comenius University, Department of Microbiology and Virology, Bratislava, Slovak Republic |
human interferon [lambda]1 and analysis of its antiviral activities against influenza and vaccinia |
|
|
|
|
|
viruses |
|
|
|
viro00495 |
* M. I. Alam (1), H. Marjuki (2), C. Erhardt (3), O. Planz (4), S. Ludwig (3), S. Pleschka (1) |
(1) Justus-Liebig-University, Institute for Medical Virology, Giessen, Germany; (2) St. Jude Children´s Res. Hospital, |
Inhibitory Action of Verapamil on Influenza A Virus Replication |
Antivirals and Resistance |
AVR004 |
|
|
Department of Infectious Diseases, |
|
|
|
|
|
Memphis, USA; (3) University Muenster, Institute for Molecular |
|
|
|
|
|
Virology, Münster, |
|
|
|
|
|
Germany; (4) Freidrich-Loeffler-Institute, |
|
|
|
|
|
Institute for |
|
|
|
|
|
Immunology, Tübingen, Germany |
|
|
|
|
viro00607 |
* Andreas Kurth (1), Anna Dunkhorst (1), |
(1) RKI, ZBS1, Berlin, Germany; (2) Charité, |
DNA Aptamers impair |
Antivirals and Resistance |
AVR005 |
|
Doreen Muth (1), Andreas Kage (2), Andreas Nitsche (1) |
Laboratory Medicine, Berlin, Germany |
Orthopoxvirus Infection |
|
|
|
viro00656 |
* Jiraporn Nikomtat (1), Yingmanee Tragoolpua (2) |
(1) Chiang Mai University, Biotechnology, Graduate School, |
Anti-Herpes Simplex Virus Type 2 activities from [I]Inula cappa[/I] |
Antivirals and Resistance |
AVR006 |
|
|
Chiang Mai, Thailand; (2) Chiang Mai University, Biology, Chiang Mai, Thailand |
(Ham.ex D.Don)DC. and [I]Cissus rependa[/I] Vahl. Extracts |
|
|
|
viro00663 |
* Raenu Yucharoen |
(1) Chiang Mai |
Efficacy of Anti- |
Antivirals and |
AVR007 |
|
(1), Yingmanee |
University, |
HSV-1 Activity of |
Resistance |
|
|
Tragoolpua (2) |
Biotechnology, Graduate School, Chiang Mai, Thailand; (2) Chiang Mai |
Some Thai Highland Plants |
|
|
|
|
University, Biology, Chiang Mai, Thailand |
|
|
|
|
viro00715 |
* Keivan Zandi (1), Parisa Pakdel (1), Kohzad Sartavi (2) |
(1) Bushehr University of Medical Sciences, Persian Gulf Health Research Center, Bushehr, Iran; (2) |
Antiviral activity of a brown alga from Persian gulf,Cystoseira myrica against |
Antivirals and Resistance |
AVR008 |
|
|
Jahad-Keshavarzi Research Center, Botany, Bushehr, Iran |
herpes simplex virus type 1 in cell culture |
|
|
|
viro00731 |
* J. Muench (1), L. Staendker (2), K. Adermann (3), A. Schulz (2), M. |
(1) Institute of Virology, University of Ulm, Ulm, Germany; (2) IPF PharmaCeuticals |
Discovery of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion |
Antivirals and Resistance |
AVR009 |
|
Schindler (1), R. Chinnadurai (1), S. Poehlmann (4), C. Chaipan (4), T. Biet (5), T. Peters (5), B. Meyer (6), D. Wilhelm (6), H. |
GmbH, Hannover, Germany; (3) VIRO Pharmaceuticals GmbH & Co. KG, Hannover, Germany; (4) University of Erlangen-Nuernberg, |
Peptide |
|
|
|
Lu (7), W. Jing (7), S. Jiang (7), W.-G. Forssmann (8), F. Kirchhoff (1) |
Erlangen, Germany; (5) University of Luebeck, Luebeck, Germany; (6) University of Hamburg, Hamburg, Germany; (7) Lindsley F. Kimball |
|
|
|
|
|
Research Institute, New |
|
|
|
|
|
York, USA; (8) Center of Pharmacology, Hannover Medical |
|
|
|
|
|
School, Hannover, |
|
|
|
|
|
Germany |
|
|
|
|
viro00811 |
* Susanne Duwe (1), |
(1) Robert Koch-Institut, |
Incidence of drug |
Antivirals and |
AVR010 |
|
Thorsten Wolff (1), Brunhilde Schweiger (1) |
Berlin, Germany |
resistant influenza A viruses in Germany |
Resistance |
|
|
viro00865 |
* Jae-Seon Hwang (1), Oliver Kregler (1), John C. Drach (2), Leroy B. Townsend (3), Rita |
(1) Institute of Virology, Charité Universtiy Hospital, Berlin, Germany; (2) |
New benzimidazole D-ribonucleosides inhibit viral DNA replication |
Antivirals and Resistance |
AVR011 |
|
Schilf (1), Elke Bogner (1) |
Department of Biologic and Materials Sciences, School of Dentistry, Ann Arbor, USA; (3) Interdepartmental Graduate Program in |
|
|
|
|
|
Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, USA |
|
|
|
|
viro00894 |
Stefanie Thulke (1), Ivonne Naumann (2), Rainer Buchholz (2), * |
(1) Charité-CCM, Onko/Häma, Berlin, Gemany; (2) FAU, BVT, |
SQDGs – potential antiviral agents? |
Antivirals and Resistance |
AVR012 |
|
Aleksandar Randonic (1), Wolfgang Siegert (1), Harald Lange (2), |
Erlangen, Germany |
|
|
|
|
Christian Walter (2) |
|
|
|
|
|
viro00904 |
* Alexandra Nordmann |
(1) Philipps University |
Antiviral Potential |
Antivirals and |
AVR013 |
|
(1), David Stein (2), Hans-Dieter Klenk (1), Gülsah Gabriel (1) |
Marburg, Institute of Virology, Marburg, Germany; (2) Avi BioPharma Inc., |
of Morpholino Oligomers Targeting NP and PB1 Genes of |
Resistance |
|
|
|
Corvallis, Oregon, United States of |
Influenza A Virus |
|
|
|
|
America |
|
|
|
|
viro00960 |
* Marcel Jonges (1), Mariken van der Lubben (1), Pieter Overduin (1), Adam Meijer (1) |
(1) National Institute for Public Health and the Environment, Laboratory for Infectious Diseases and Screening, Bilthoven, |
Antiviral susceptibility of Dutch seasonal influenza viruses |
Antivirals and Resistance |
AVR014 |
|
|
NLD |
|
|
|
|
viro00968 |
* Hans Josef Schramm (1), Wolfgang Schramm (1) |
(1) LMU, Hemostaseology, München, Germany |
Interface targeting peptides as inhibitors of HIV |
Antivirals and Resistance |
AVR015 |
|
|
|
protease – an update |
|
|
|
viro00986 |
* A. Stankiewicz-Drogon (1), V. Kostina |
(1) Institute of Biochemistry and |
Acridone derivatives as |
Antivirals and Resistance |
AVR016 |
|
(2), L. Palchykovska (2), A. Alexeeva (2), A.D. Shved (2), A.M. Boguszewska-Chachulska (1) |
Biophysics PAS, Warsaw, Poland; (2) Institute of Molecular Biology and Genetics NAS, Kiev, Ukraine |
potential anti-HCV agents |
|
|
|
viro00990 |
* Koen Janssens (1), Bruno Pot (1), Luc |
(1) Applied Maths NV, Sint-Martens-Latem, |
An open HIV Drug Resistance |
Antivirals and Resistance |
AVR017 |
|
Vauterin (1), Paul Vauterin (1) |
Belgium |
[I]Expert Rule System[/I] in the BioNumerics® |
|
|
|
|
|
software |
|
|
|
viro01066 |
* Ingrid Hülsmeyer (1), Stephan Kremb (2), Horst Wolff (2), Dieter |
(1) GSF, Immune Monitoring Unit, Munich, Germany; (2) |
Detection of cellassociated early HIV gene |
Antivirals and Resistance |
AVR018 |
|
Hoffmann (3), Hermann Schätzl (3), Ruth Brack-Werner (2) |
GSF, IMV, Neuherberg, Germany; (3) TUM, Institut für Virologie, Munich, Germany |
expression on single cell level |
|
|
|
viro01069 |
* Beatrice Mercorelli (1), Giulia Muratore (1), Elisa Sinigalia (1), |
(1) Univ Padova, Dept Histol, Microbiol & Med Biotech, Padova, Italy; |
A new 6aminoquinolone, WC5, with specific |
Antivirals and Resistance |
AVR019 |
|
Maria A Biasolo (1), Oriana Tabarrini (2), Violetta Cecchetti (2), Arianna Loregian (1), Giorgio Palù (1) |
(2) Univ Perugia, Dept.Chem & Technol Drugs, Perugia, Italy |
anti-HCMV activity |
|
|
|
viro01136 |
* Martin Obermeier (1), Raymund Buhmann |
(1) Max von Pettenkofer Institut, Virology, |
Oligonucleotide based drug |
Antivirals and Resistance |
AVR020 |
|
(2), Gundula Jäger (1) |
Munich, Germany; (2) LMU, Medicine III, Munich, Germany |
reduces activity of acyclovir (ACV) against HSV |
|
|
|
viro01140 |
* Martin Obermeier (1), Hans Nitschko (1), Josef Eberle (1), Gundula Jäger (1) |
(1) Max von Pettenkofer Institut, Virology, Munich, Germany |
Fully automated analysis of Hepatitis B Sequences for interpretation of |
Antivirals and Resistance |
AVR021 |
|
|
|
drug resistance and |
|
|
|
|
|
HBs-antigen |
|
|
|
|
|
escape mutations |
|
|
|
viro01165 |
* Svetlana Rak (1), Elena Goncharova (1), Ilya Vinogradov (2), |
(1) SRC VB Vector, Vaccines and Antivirals, Koltsovo, Russia; (2) |
Virucidal properties of low-molecular polyvalent inhibitor |
Antivirals and Resistance |
AVR022 |
|
Elena Ryabchikova (2), Alexander Ryzhikov (1) |
SRC VB Vector, Microscopy, Koltsovo, Russia |
of influenza virus hemagglutinin |
|
|
|
viro01244 |
Christina Ehrhardt (1), * Eike R Hrincius (1), Virginia Korte (1), Igor Mazur (1), Karoline |
(1) Institute for Molecular Virology, WWU, Münster, Germany; (2) FLI, |
CYSTUS052, a polyphenol rich plant extract, exerts potent anti- |
Antivirals and Resistance |
AVR023 |
|
Droebner (2), Anne Pötter (3), Mirco Schmolke (1), Oliver Planz (2), Stephan Ludwig (1) |
Tübingen, Germany; (3) Dr. Pandalis Naturprodukte GmbH, Glandorf, Germany |
influenza virus activity in cell culture |
|
|
|
viro01276 |
* A. Hahn (1), J. Geiler (1), P. Nazck (1), M. |
(1) Institut für Medizinische Virologie, |
Glycyrrhizin for the Treatment of Highly |
Antivirals and Resistance |
AVR024 |
|
Michaelis (1), H. W. Doerr (1), J. Cinatl Jr. (1) |
Universitätsklinikum, Frankfurt/Main, Germany |
Pathogenic Influenza H5N1 Infection |
|
|
|
viro01281 |
* Woo-Young Choi (1), Min-Ji Kim (1), Nam-Joo Lee (1), Hyun-Jung Ju (1), Joo-Yeon Lee |
(1) Korean CDC, Div.of Influenza & Respiratory Viruses, Seoul, Republic of Korea |
Monitoring of Amantadine Resistant Influenza A Korean Isolates |
Antivirals and Resistance |
AVR025 |
|
(1), Hee-Bok Oh (1), Hae-Wol Cho (1), Chun Kang (1) |
|
by Pyrosequencing |
|
|
|
viro01307 |
* Stanislav Markushin (1), Sergey Artyushenko (1), Nikholai Kontarov (1), |
(1) Mechnikov Research Institute for Vaccines and Sera, virology, Moscow, |
Mechanisms of antiviral effect of a boroadamantane derivative BG-12 |
Antivirals and Resistance |
AVR026 |
|
Yuri Bubnov (2) |
Russia; (2) Zelinsky Research Institute of |
|
|
|
|
|
Organic Chemistry, Moscow, Russia |
|
|
|
|
viro01367 |
M Sturmer (1), P Gute (2), S Klauke (3), S Staszewski (1), * HW |
(1) JWG-Univ. Hosp., FFM, Ger; (2) HIV SP, FFM, Ger; (3) IFS, |
Subtype-Dependent Increase of Drug |
Antivirals and Resistance |
AVR027 |
|
Doerr (1), P Lecocq (4), M Van Houtte (4) |
FFM, Ger; (4) Virco BVBA, Mechelen, Bel |
Resistance Score for Tipranavir in PInaïve HIV-1 |
|
|
|
|
|
Infected Patients: |
|
|
|
|
|
Bias of the |
|
|
|
|
|
Algorithm or Lower |
|
|
|
|
|
Genetic Barrier in |
|
|
|
|
|
Non-B Subtypes? |
|
|
|
viro01390 |
* Anna Maisa (1), Ute Ströher (2), Carolin Weise (1), Wolfgang Garten (1), Thomas Strecker (1) |
(1) Institute of Virology, Philipps University, Marburg, Germany; (2) NML, Public Health Agency of Canada, |
Bioengineered [alpha]1-Antitrypsin variants are potential inhibitors for the Lassa virus |
Antivirals and Resistance |
AVR028 |
|
|
Winnipeg, Canada |
glycoprotein activating protease SKI-1/S1P |
|
|
|
viro01395 |
* Melanie Balduin (1), Herbert Pfister (1), Mark Oette (2), Rolf Kaiser (1) |
(1) Institute of Virology, University, Cologne, Germany; (2) Dept. Gastroenterology, |
Detection of minorities at reverse transcriptase |
Antivirals and Resistance |
AVR029 |
|
|
University, Duesseldorf, |
K103N of HIV |
|
|
|
|
Germany |
strains in therapy |
|
|
|
|
|
naive patients |
|
|
|
viro01442 |
Jan Felix Drexler (1), Luciano Luna (2), |
(1) Hospital Universitario Prof. |
Rates and reasons of failure of |
Antivirals and Resistance |
AVR030 |
|
Eduardo Netto (1), * Christian Drosten (2) |
Edgard Santos, Salvador, Brazil; (2) Bernhard Nocht |
commercial HIV-1 viral load assays in Brazil |
|
|
|
|
Institute for Tropical Medicine, Clinical |
|
|
|
|
|
Virology, Hamburg, |
|
|
|
|
|
Germany |
|
|
|
|
viro01484 |
Marco Axmann (1), * Susanne Pfefferle (2), Anna-Winona Struck (1), Christian Drosten (2), Bernd Meyer (1) |
(1) University of Hamburg, Institute of Organic Chemistry, Hamburg, Germany; (2) Bernhard Nocht Institute for Tropical |
A hexapeptide that blocks SARS-Coronavirus receptor binding |
Antivirals and Resistance |
AVR031 |
|
|
Medicine, Clinical |
|
|
|
|
|
Virology, Hamburg, Germany |
|
|
|
|
viro01491 |
* Katharina Göhring (1), Elfriede Mikeler (1), Gerhard Jahn (1), Klaus Hamprecht (1) |
(1) Institute of Medical Virology, University Hospital of Tuebingen, 72076 Tuebingen, |
Characterisation of clinical HCMV strains with multiple UL97 and UL54 |
Antivirals and Resistance |
AVR032 |
|
|
Germany |
mutations |
|
|
|
viro01556 |
* Sybille Somogyi (1), Ralitsa Valchanova (1), Stefan Neifer (2), Thomas Berg (2), Frank Schlote (3), Katrin Arndt (1), |
(1) Robert Koch-Institute, Berlin, Germany; (2) Diagnostic Laboratory, Berlin, Germany; (3) Medical Practice, Berlin, |
Evolution and persistence of transmitted multiresistant HIV-1 |
Antivirals and Resistance |
AVR033 |
|
Claudia Kuecherer (1) |
Germany |
|
|
|
|
viro01586 |
Nadav Orr (1), Israel Nur (1), Orgad Laub (1), Yitzhak Samina (2), Yevgeni Khimich (2), Ahuva Gottreich (3), Michael Simanov |
(1) Omrix Pharmaceuticals, MDA Blood Center, Tel Hashomer Hospital, Kiryat Ono, Israel; (2) Veterinary Inst., |
WNIG for treatment of West Nile infection |
Antivirals and Resistance |
AVR034 |
|
(2), * Bracha Rager-Zisman (4), David Ben Nathan (4) |
Virology, Beit Dagan, Israel; (3) MDA Blood Center, Tel Hashomer Hospital, Kiryat Ono, Israel; (4) Ben Gurion University, Microbiology |
|
|
|
|
|
and Immunology, Beer Sheva, Israel |
|
|
|
|
viro01598 |
* Julian WT Tang (1), Karry LK Ngai (1), Jianlin Shao (2), Wai Y Lam (1), Sai M Ngai (2), Paul KS Chan (1) |
(1) The Chinese University of Hong Kong, Microbiology, Hong Kong SAR, China; (2) The Chinese |
New emerging neuraminidase mutations in Hong Kong influenza A(H3N2) viruses |
Antivirals and Resistance |
AVR035 |
|
|
University of Hong Kong, Biology, Hong Kong SAR, China |
1997-2006: antigenic drift or drug resistancerelated? |
|
|
|
viro01645 |
* Ksenia Pumpor (1), Koen Verschueren (1), Rolf Hilgenfeld (1) |
(1) University of Luebeck, Institute of Biochemistry, Lübeck, |
Crystallography-Driven Inhibitor Design: Preventing |
Antivirals and Resistance |
AVR036 |
|
|
Germany |
Activation of the |
|
|
|
|
|
SARS-CoV Main |
|
|
|
|
|
Proteinase |
|
|
|
viro01669 |
Eva Bernhoff (1), Tore J Gutteberg (1), Kjersti Sandvik (1), Hans H |
(1) University Hospital of North Norway, Microbiology and |
Effect of Cidofovir on Polyomavirus BK Replication |
Antivirals and Resistance |
AVR037 |
|
Hirsch (2), * Christine H Rinaldo (1) |
Infection Control, Tromsø, Norway; (2) University of Basel, Transplantation Virology, Basel, Switzerland |
|
|
|
|
viro01673 |
* F. G. Hermann (1), S. |
(1) Georg-Speyer-Haus, |
In vitro selection of |
Antivirals and |
AVR038 |
|
Lohrengel (2), M. Dittmar (2), U. Dietrich (1), D. von Laer (1) |
Frankfurt, Germany; (2) Universität Heidelberg, Heidelberg, Germany |
HIV-1 with resistance towards the fusion inhibitor maC46 |
Resistance |
|
|
viro01714 |
Maren Eggers (1), * Berit Erbes (2), C. Benzinger (1), Th |
(1) Labor Enders und Partner, Institute for Virology, Infectiology |
A novel approach to validate disinfectants |
Antivirals and Resistance |
AVR039 |
|
Regnath (1), M Enders (1), Stephan Urban (2) |
und Epidemiology e.V., Stuttgart, Germany; (2) University of Heidelberg, Dept. Mol. Virology, Otto Meyerhof Zentrum, Heidelberg, |
against human hepatitis B virus using a cell culture system supporting the full replication cycle |
|
|
|
|
Germany |
|
|
|
|
viro01730 |
Poster Session III